JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 20, 2003; DOI: 10.1124/jpet.103.057646


0022-3565/04/3081-134-142$20.00
JPET 308:134-142, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.057646v1
308/1/134    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brandts, B.
Right arrow Articles by Trappe, H.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brandts, B.
Right arrow Articles by Trappe, H.-J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMIODARONE HYDROCHLORIDE

CARDIOVASCULAR

Inhibition of G Protein-Coupled and ATP-Sensitive Potassium Currents by 2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015), an Amiodarone Derivative

B. Brandts, R. Borchard, R. Macianskiene, V. Gendviliene, D. Dirkmann, M. Van Bracht, M. Prull, M. Meine, I. Wickenbrock, K. Mubagwa, and H.-J. Trappe

Department of Cardiology, Marienhospital Herne, University of Bochum, Herne, Germany (B.B., R.B., D.D., M.V.B., M.M., M.P., I.W., H.J.T.); Centre for Experimental Surgery and Anaesthesiology, University of Leuven, Leuven, Belgium (R.M., K.M.); and Laboratory of Membrane Biophysics, Institute of Cardiology, Kaunas, Lithuania (R.M., V.G.).

2-Methyl-3- (3,5-diiodo-4-carboxymethoxybenzyl) benzofuran (KB130015; KB), a novel compound derived from amiodarone, has been proposed to have antiarrhythmic properties. Its effect on the G protein-coupled inward rectifying K+ current [IK(ACh)or IK(Ado)], ATP-sensitive K+current [IK(ATP)], and background inward rectifying current (IK1) were studied in guinea pig atrial and ventricular myocytes by the wholecell voltage-clamp technique. Receptor-activated IK(ACh/Ado), induced in atrial myocytes by the stimulation of either muscarinic or Ado receptors was concentration dependently (IC50value of {approx}0.6-0.8 µM) inhibited by KB. Receptor-independent guanosine 5'-O-(3-thio)triphosphate-induced and background IK(ACh), which contributes to the resting conductance of atrial myocytes, were equally sensitive to KB (IC50value of {approx}0.9 µM). IK(ATP)induced in atrial myocytes during metabolic inhibition with 2,4-dinitrophenol (DNP) was also suppressed by KB, whereas IK1measured in ventricular myocytes was insensitive to the drug (KB <=50 µM). Although being effective when applied from the outside, intracellular application of KB via the patch pipette affected neither IK(ACh) nor IK(ATP). 3,3',5-triodo-L-thyronin, which shares structural groups with KB, did not have an effect on the K+currents. Consistent with the effects on single myocytes, KB did not depolarize the resting potential but antagonized the shortening of action potential duration by carbamylcholine-chloride or by DNP in multicellular preparations and antagonized the shortening of action potential duration by acetylcholine in single myocytes. It is concluded that KB inhibits IK(ACh)and IK(ATP)by direct drug-channel interaction at a site more easily accessible from extracellular side of the membrane.


Received August 5, 2003; accepted September 29, 2003.

Address correspondence to: Dr. Bodo Brandts, Medizinische Klinik II/Universitätsklinik Marienhospital Herne, Ruhr-Universität Bochum, Hölkeskampring 40, D-44625 Herne, Germany. E-mail: bodo.brandts{at}ruhr-uni-bochum.de







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.